This inventor holds 1 USPTO granted patent. Top assignees: Dartmouth College, Somatogenetics International, Inc.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 708 
1 out of 2 Years Active: 1989
Title: Michael Sinensky: Innovator in Cholesterol Regulation
Introduction
Michael Sinensky is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cholesterol regulation. His innovative work has the potential to impact health and wellness positively.
Latest Patents
Michael Sinensky holds a patent for "Squalene oxide cyclase inhibitors and therapeutic use thereof." This patent focuses on Azadecalins and C-7 substituted decalins, which exhibit squalene oxide cyclase inhibitory activity. These compounds are useful as inhibitors of cholesterol synthesis and may be employed in pharmaceuticals aimed at regulating cholesterol levels in mammals. He has 1 patent to his name.
Career Highlights
Throughout his career, Michael has worked with various organizations, including Somatogenetics International, Inc. and Dartmouth College. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Michael has collaborated with Thomas A. Spencer, enhancing his research and development efforts in the field of cholesterol regulation.
Conclusion
Michael Sinensky's contributions to the pharmaceutical industry, particularly in cholesterol regulation, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile